Peak Bio
About:
Peak Bio is a Biopharmaceutical company that focuses on the drug development to treat Oncology and Inflammatory diseases.
Website: https://peak-bio.com/
Top Investors: Palo Alto Investors, Hoyoung Huh
Description:
Peak Bio is a Biopharmaceutical company that focuses on the drug development to treat Oncology and Inflammatory diseases.
Total Funding Amount:
$25M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Palo Alto, California, United States
Founded Date:
2015-01-01
Contact Email:
Admin(AT)peak-bio.com
Founders:
Hoyoung Huh
Number of Employees:
11-50
Last Funding Date:
2022-11-02
IPO Status:
Public
Industries:
© 2025 bioDAO.ai